Clinical trial
Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without…
NCT00340691 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00340691 |
|---|---|
| Title | Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic Filariasis |
| Official title | Treatment of Mansonella Perstans Infection in an Area Coendemic for Lymphatic Filariasis: A Pilot Study of the Effects of Doxycycline |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mansonella Perstans Infection, Mp Microfilaremia |
| Intervention type | Drug |
| Interventions | Doxycycline |
| Enrollment | 1,500 |
| Start date | Dec 6, 2004 |
| Primary completion | Oct 4, 2007 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: